Account
Insider Insights
30.01.2024
New MHRA procedure can accelerate patient access t...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...

Read more
Insider Insights
06.12.2023
New rebate percentages in the Statutory Scheme are...

The statutory scheme has been updated with new percentages for 2024-2026, and has received backlash ...

Read more
Insider Insights
04.12.2023
To improve Germany’s attractiveness, confidentia...

Germany’s Health minister has announced that publicly listed AMNOG rebates could be replaced by co...

Read more
Insider Insights
22.11.2023
AIFA reform set to move forward after receiving th...

AIFA reform is a landmark change which propels Italy towards expedited drug approvals and improved a...

Read more
Insider Insights
21.11.2023
World’s first CRISPR medicine approved in UK for...

The MHRA grants conditional approval to Casgevy, the first-ever CRISPR gene-editing therapy for sick...

Read more
Insider Insights
21.11.2023
Landmark deal reached on UK voluntary rebate schem...

Government, NHS, and Pharma Industry Unveil Successor to Voluntary Scheme for Branded Medicines Pric...

Read more
Insider Insights
06.10.2023
Germany’s Health Ministry Shifts Focus to Di...

Germany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...

Read more
Insider Insights
02.10.2023
AIFA Reform: CPR and CTS committees extended again

Discover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR ...

Read more
Insider Insights
29.09.2023
Switzerland's 2024 Medicine Access Reforms

Switzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an...

Read more
Insider Insights
21.09.2023
France's €1B 2024 Reimbursement Savings Goal

French government's ambitious plan to save €1 billion in healthcare expenses by 2024 through new r...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.